ADVANCED NSCLC
Clinical trials for ADVANCED NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own tumor cells fight your lung cancer? new trial explores
Disease control Recruiting nowThis study tests whether specially selected immune cells taken from a patient's own lung tumor can be grown in a lab and then given back to shrink advanced non-small cell lung cancer. About 85 adults aged 18–72 with stage IV or unresectable disease and a tumor that can be safely …
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New hope for advanced lung cancer patients: experimental combo targets tumors from two angles
Disease control Recruiting nowThis study tests a new drug called JS207, which targets two proteins (PD-1 and VEGF) that help tumors grow. It is given alone or with another drug (JS004 or docetaxel) to 66 adults with advanced non-small cell lung cancer that got worse after standard chemotherapy and immunothera…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC